FX.co ★ HCA Healthcare Q4 Beats Market, Sees Growth In FY25; Declares Dividend- Update

HCA Healthcare, Inc. announced a lukewarm fourth-quarter profit report on Friday, although it surpassed market predictions. Additionally, the company provided a promising fiscal outlook for 2025, surpassing the previous year's figures, and revealed a dividend announcement.

For fiscal year 2025, HCA anticipates a net income attributable to shareholders ranging between $5.85 billion and $6.29 billion, translating to earnings of $24.05 to $25.85 per share. Expected revenues are forecasted to fall between $72.80 billion and $75.80 billion.

Wall Street analysts predict the company will achieve earnings of $24.61 per share on revenues totaling $74.81 billion, although these estimates typically exclude any one-time items.

In fiscal year 2024, HCA reported a net income of $5.76 billion or $22.00 per share, with total revenues reaching $70.603 billion.

Moreover, HCA has declared a quarterly cash dividend of $0.72 per share, as approved by its Board of Directors. This dividend is scheduled for disbursement on March 31 to shareholders recorded by the close of business on March 17.

During the fourth quarter, HCA Healthcare recorded earnings of $1.438 billion, or $5.63 per share, a decrease from the previous year's $1.607 billion or $5.93 per share. Adjusted earnings for this period stood at $6.22 per share, slightly exceeding analysts' expectations of $6.14 per share.

Revenue for the quarter rose by 5.7% to $18.285 billion compared to last year's $17.303 billion.

Pre-market trading on the NYSE saw HCA Healthcare shares increase around 1.4%, reaching $329.79.